Growing number of patients being treated in NICUs, ICUs, and emergency departments is increasing the demand for blood gas and electrolyte analyzers

Also, increasing number of patients suffering from chronic diseases and cancer, contributes to growth of the blood gas and electrolyte analyzers market. Additionally, advancements in blood gas and electrolyte analyzers, and increasing number of product approvals are major factors favoring growth of the blood gas and electrolyte analyzers market. However, complexity involved in the interpretation of blood analysis data hinders growth of the market.

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/533

Blood gas analyzers and electrolyte analyzers are sued to measure parameters of combinations of pH, blood gas, electrolytes, and metabolites from whole blood samples. The pH value of blood and plasma or serum is an indicator of the balance between the renal (kidney), blood, and lung. Where pCOvalue of arterial blood is used to access efficient elimination of carbon dioxide from the body. Whereas a by-product of metabolism and the pOvalue of arterial blood is the measure of oxygen absorbance by the body in the lungs. Metabolites and electrolytes provide further information about metabolism.

Growing geriatric population fuels growth of the blood gas and electrolyte analyzers market

Growing geriatric population, who are at increased risk for acquiring cancer development and chronic diseases, which require frequent testing of blood gas testing and point-of-care (PoC) diagnostic evaluation, which projects growth of the blood gas and electrolyte market. According to W.H.O, around 3 million deaths were caused by chronic diseases, globally, in 2015, accounting for 5% of all the death globally in that year. This in turn led to significant increase in traffic of emergency cases, thus creating high demand for blood gas and electrolyte analyzers.

Regional growth engines of the blood gas and electrolyte analyzers market

According to W.H.O, over three quarters of chronic disease take place in low-and middle-income countries, as they do not have the benefit of primary integrated programmes for early detection and treatment as compared to people in high income countries, which is expected to increase growth of the market in Asia Pacific. In the Middle East and Africa, the United Nations Fund for Population Activities (UNFPA) introduced Country Program Action Plan (CPAP) to prevent diseases. This in turn is expected to create new opportunities for growth of the blood gas and electrolyte analyzers market.

To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/533

Key players supporting growth of the blood gas and electrolyte analyzers market

Manufacturers are focused on miniaturization technology for development of advanced, sleek, compact, handheld instruments. Key players operating in the blood gas and electrolyte analyzers are Siemens Healthcare GmbH, Radiometer India (division of DHR Holding (India) Pvt Ltd.), Instrumentation Laboratories, Inc., F. Hoffmann-La Roche Ltd, Cerner Corporation, and Alere. 

You may be interested

Protein Assays Market Growth Analysis,Opportunities Forecasts Report till 2026
Business
Business

Protein Assays Market Growth Analysis,Opportunities Forecasts Report till 2026

Albert R - November 14, 2018

“Protein Assays Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released Protein Assays Market research report.…

X-ray Market Research 2018 | Development, Revenue, Growth Rate and Forecast 2026
Business
Business

X-ray Market Research 2018 | Development, Revenue, Growth Rate and Forecast 2026

Albert R - November 14, 2018

X-ray Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released X-ray Market research report. The report…

Global Rare Disease Drugs – Competitive Analysis Market Headed for Growth and Global Expansion by 2026
Healthcare
Healthcare

Global Rare Disease Drugs – Competitive Analysis Market Headed for Growth and Global Expansion by 2026

Albert R - November 14, 2018

Global Rare Disease Drugs - Competitive Analysis Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released…

Most from this category